Document:

RESOLUTION
OF THE BOARD OF DIRECTORS FOR

US
NUCLEAR CORP.

 

Pursuant
to Article IV, Section 5 of the Bylaws (the “Bylaws”) of US Nuclear Corp., a Delaware corporation (the “Company”),
the Board of Directors of the adopts the following resolutions:

 

RESOLVED,
the Board of Directors ratifies and approves the May 4, 2012 amendment to the Company’s Articles of Incorporation, as being
in the best interests of the Company.

 

RESOLVED,
with Gerald Entine abstaining from the vote, the Board of Directors accepts the appointment of Gerald Entine to serve on the Board
of Directors as nominated by the majority shareholders pursuant to Article IV, Section 1, Article III, Section 3 and Article III,
Section 8 of the Bylaws, and ratifies the issuance of 10,000 shares of the Company’s restricted common stock to Mr. Entine
in lieu of compensation pursuant to the April 30, 2015 Restricted Stock Agreement between the Company and Mr. Entine, as being
in the best interests of the Company.

 

RESOLVED,
with Robert Goldstein abstaining from the vote, Mr. Entine is authorized on behalf of the Company to execute the Assignment
of Contractual Rights dated January 26, 2016, but effective April 11, 2012, between Optron Scientific Company, Inc. (“Optron”),
Overhoff Technology Corporation (“Overhoff”), US Nuclear Corp., Inc., the dissolved Delaware corporation, and the
Company (the “Assignment”).
The Board of Directors resolves to waive any and all actual or perceived conflicts in Mr. Goldstein being a party to the Assignment
and in serving as Chairman of the Board of Directors for the Company.

 

RESOLVED,
with Mr. Goldstein abstaining from the vote, the Board of Directors ratifies Mr. Goldstein’s execution of the Engagement
Letter on behalf of the Company with Richard Chiang dated May 14, 2012 (the “Chiang Engagement Letter”), as being
in the best interests of the Company.

 

RESOLVED,
with Mr. Goldstein abstaining from the vote, the Board of Directors ratifies Mr. Goldstein’s issuance of 850,000 shares
of restricted common stock held in his name to Mr. Chiang on May 12, 2012 pursuant to the Chiang Engagement Letter. The Board
of Directors further ratifies the sale of 700,000 shares of the Company restricted common stock to Mr. Chiang on August 15, 2013
under the Chiang Engagement Letter.

 

RESOLVED,
the Board of Directors ratifies Mr. Chiang’s appointment to the Board of Directors on May 18, 2012, and ratifies his subsequent
resignation on March 31, 2013, notwithstanding the ongoing relationship at the time with Mr. Chiang under the Chiang Engagement
Letter.

 

RESOLVED,
with Mr. Goldstein abstaining from the vote, the Board of Directors ratifies Mr. Goldstein’s prior resignation as Chief
Financial Officer of the Company on October 15, 2013, and ratifies the successor appointment of Darian Anderson to serve in this
capacity.

 

RESOLVED,
the Board of Directors ratifies its agreement with Mr. Anderson to issue 25,000 shares of restricted common stock in the Company
to him for providing services to the Company in lieu of compensation. The Board of Directors ratifies Mr. Anderson’s subsequent
resignation as Chief Financial Officer, but preserves any and all claims, if any, unless otherwise waived by the Company.

 

RESOLVED,
the Board of Directors ratifies the subsequent appointment of Rachel Boulds to serve as Chief Financial Officer, and ratifies
the Board of Directors’ agreement to issue Ms. Boulds 25,000 shares of restricted common stock in the Company for providing
services to the Company, in addition to $2,500 per quarter during the term of her agreement. The Company ratifies Ms. Boulds’
October 16, 2014 Employment Agreement as being in the best interests of the Company.

 

    	-1- 

    	 

    

RESOLVED,
with Mr. Goldstein abstaining from the vote, the Board of Directors ratifies, and approves any and all corporate action taken
with respect to the Agreement and Plan of Merger, Stock Exchange Agreement and Cancellation Agreement between and amongst US Nuclear
Acquisition Corp., Optron and Overhoff, and Mr. Goldstein and the Company, as set forth in the December 19, 2013 Form 8-K, as
being in the best interests of the Company.

 

RESOLVED,
the law firm of Paesano Akkashian Apkarian, P.C. is authorized to take any and all necessary action in filing disclosure schedules
or forms with the United States Securities and Exchange Commission with direct oversight and approval by Mr. Goldstein.

 

RESOLVED,
the Board of Directors ratifies and agrees to indemnify any and all directors or officers under Article XI of the Bylaws.

 

RESOLVED,
the Board of Directors ratifies and approves all prior actions by the officers of the Company as being in the best interests of
the Company.

 

			DATED: January
                                         28, 2016

 

			Approved
                                         for Adoption:

 

	APPROVED:

         

	/s/ Robert I.
        Goldstein

        By: Robert I. Goldstein

        Chairman of the Board

        Except Where Abstaining

         

         

        /s/ Gerald Entine

        By: Gerald Entine

        Director

        Except Where Abstaining

         

    	-2-ASSIGNMENT
OF CONTRACTUAL RIGHTS

 

This
Assignment of Contractual Rights (this “Assignment”) is effective April 11, 2012 although it is being entered
into the parties hereto on January 29, 2016. This Assignment is entered into between Optron Scientific Company, Inc., a California
corporation doing business as Technical Associates with a mailing address for notice purposes of 7051 Eton Avenue in Canoga Park,
California 91303 (collectively referred to herein as “Optron”), Overhoff Technology Corporation, an Ohio corporation,
with a mailing address for notice purposes of 1160 U.S. Route 50 in Milford, Ohio, and wholly owned subsidiary of Optron (“Overhoff”),
US Nuclear Corp., Inc., a dissolved Delaware corporation with a mailing address for notice purposes of 7051 Eton Avenue in Canoga
Park, California 91303 (“US Nuclear”), US Nuclear Corp., a Delaware corporation and reporting company under the rules
promulgated by the United States Securities and Exchange Commission (the “SEC”) with a mailing address for notice
purposes of 7051 Eton Avenue in Canoga Park, California 91303 (“US Nuclear Corp.”), and Robert I. Goldstein, an individual,
and control person of Optron, Overhoff and US Nuclear, with a mailing address for notice purposes of 7051 Eton Avenue in Canoga
Park, California 91303 (“Goldstein”)(collectively, the “Parties”).

 

WHEREAS,
on April 12, 2012, the Parties, individually and/or collectively, entered into a Share Purchase Agreement (the “SPA”)
with Richard Chiang, who at the time was the sole shareholder of Apex 3, Inc., a Delaware corporation that amended its Articles
of Incorporation on May 4, 2012 changing the name of the corporation to US Nuclear Corp. The US Nuclear set forth in the SPA was
dissolved prior to the consummation of the SPA in order for the name “US Nuclear Corp.” to be used as the successor
to Apex 3, Inc., as set forth above.

 

WHEREAS,
under the SPA, the Parties agreed that the purchaser of the shares was “US Nuclear Corp dba Technical Associates, Inc. and
Overhoff Corp, and/or his assigns....”

 

WHEREAS,
at the time of the execution of the SPA, US Nuclear, Overhoff and Optron intended to execute this Assignment assigning their respective
rights to acquire the shares to Goldstein. Goldstein proceeded to purchase the shares under the SPA from Richard Chiang, but this
Assignment was not executed.

 

WHEREAS,
the Parties wish to memorialize their agreement to this Assignment, and in turn, authorize US Nuclear Corp. (not to be confused
with US Nuclear) to make any and all necessary disclosures with the SEC.

 

NOW,
THEREFORE, in consideration of the mutual covenants and Assignments hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.
Consideration for Assignment. In consideration for the assignment of the
rights of Optron, Overhoff and US Nuclear to Goldstein under the SPA, Goldstein had agreed to perform the respective duties and
obligations of Optron, Overhoff and US Nuclear under the SPA. The Parties acknowledge that the consideration was sufficient and
adequate, and performed by the Parties with no qualification or objection.

 

2.
No Assumption of Liabilities. The Parties do not assume any liabilities of
the other under such liability arose under the performance of the SPA, which Goldstein agreed to assume as part of his consideration
for this Assignment.

 

3.
Representations and Warranties. The Parties mutually represent and warrant
as follows:

 

    	-1- 

    	 

    

 

3.1
Capacity and Authority. Each party has the requisite power and authority to execute and deliver this Assignment and to
perform their respective duties and obligations hereunder. The execution, delivery and performance of this Assignment has been
duly authorized by all necessary action on the part of the respective parties, and constitutes a legal, valid and binding obligation
of the Parties, enforceable against each party, except as such enforceability may be limited by: (i) applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors' rights generally; and (ii) general
principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

 

3.2
Violation of Law or Assignment. The execution, delivery and performance by each party of this Assignment, and the consummation
of the transactions contemplated hereby, do not and will not conflict with or result in a violation or breach of, or default under,
any provision of the certificate of organization or articles of incorporation of any of the Parties, or other organizational documents
of either party as the case may be.

 

3.3
Consents and Approvals. All consents, approvals or authorizations of, or registrations, filings or declarations with, any
governmental authority or any other person, or other action required in connection with the execution, delivery and performance
of this Assignment by either party have been obtained by that particular party.

 

3.4
Full Disclosure. No representation or warranty by either party in this Assignment contains any untrue statement of a material
fact, or omits to state a material fact necessary to make the statements contained therein, in light of the circumstances in which
they are made, not misleading.

 

3.5
Survival. The representations, warranties and covenants of each of the parties shall survive during and after the full
performance of the obligations under this Assignment. Each party may rely on such representations, warranties and covenants irrespective
of any investigation made, or notice or knowledge held, by it or any other person.

 

4.
Miscellaneous. The Parties agree to the following miscellaneous provisions:

 

4.1
Entire Agreement. This Assignment constitutes the full and entire understanding and agreement between the Parties hereto
with respect to the subject matter hereof and supersedes all prior agreements, written or oral, with respect thereto.

 

4.2
Severability. If one or more provisions of this Assignment are held to be unenforceable under applicable law, such provision
shall be excluded from this Assignment and the balance of the Assignment shall be interpreted as if such provision were so excluded
and shall be enforceable in accordance with its terms.

 

4.3
Governing Law. This Assignment shall be governed by and construed under the laws of the State of California without regard
to choice of law principles.

 

4.4
Tax Responsibilities. The Parties agree to be responsible for their own tax liabilities, if any, as a result of this Assignment.

 

4.5
Limitation of US Nuclear Corp. Agreement. US Nuclear Corp. was not a party to the SPA. US Nuclear Corp. has agreed that
the execution of this Assignment is in its best interests; however, its limitation under this Assignment is simply approving the
Assignment, and is not bound by any other duties or obligations as a result of this Assignment or the SPA.

 

    	-2- 

    	 

    

 

4.6
Further Assurances. Each party shall, at the request of another party, at any time and from time to time following the
execution of this Assignment, promptly execute and deliver, or cause to be executed and delivered, all such further instruments
and take all such further action as each party may reasonably request to confirm or carry out the provisions and intent of this
Assignment.

 

4.7
Counterparts; Facsimile. This Assignment may be executed in counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Signatures to this Assignment may be transmitted by facsimile
and signatures so transmitted will be deemed to be original signatures.

 

4.8
Conflict Disclosure and Waiver. Goldstein is the authorized control person for, and will be executing this Assignment on
behalf of, Optron, Overhoff, US Nuclear and US Nuclear Corp., and he is executing this Assignment in his personal capacity as
well. To the extent a conflict exists, such a conflict is waived since the interests of the Parties is aligned and this Assignment
sets forth the intent of the Parties at the time of consummation of the SPA.

 

4.6
Construction and Conflict Disclosure. The Parties have participated jointly in the negotiation and drafting of this
Assignment. If an ambiguity or question of intent or interpretation arises, this Assignment shall be construed as if drafted jointly
by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship
of any of the provisions of this Assignment. US Nuclear Corp. is represented in this Assignment by Anthony R. Paesano and Paesano
Akkashian Apkarian, P.C., a Michigan professional corporation (“PAA”). Optron, Overhoff, US Nuclear and Goldstein
represent and warrant that they have retained counsel separate from PAA in reviewing and approving this Assignment. The Parties
acknowledge that PAA has advised all parties to seek independent legal counsel in connection with execution of this Assignment.

 

[SIGNATURES
ON NEXT PAGE]

 

    	-3- 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Assignment as of the date first above written.

 

 

US
NUCLEAR CORP, a Delaware corporation

 

 

/s/
Gerald Entine

By:
Gerald Entine

Its:
Authorized Director

 

US
NUCLEAR CORP, a dissolved Delaware corporation,

 

/s/
Robert I. Goldstein

By:
Robert I. Goldstein

Its:
Former Chief Executive Officer

 

OPTRON
SCIENTIFIC COMPANY, INC., a California corporation

 

/s/
Robert I. Goldstein

By:
Robert I. Goldstein

Its:
Chief Executive Officer

 

OVERHOFF
TECHNOLOGY CORPORATION, an Ohio corporation, by its sole shareholder,

 

OPTRON
SCIENTIFIC COMPANY, INC., aCalifornia corporation

 

/s/
Robert I. Goldstein

By:
Robert I. Goldstein

Its:
Chief Executive Officer 

 

/s/
Robert I. Goldstein

Robert
I. Goldstein

 

    	-4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]